(Q40449036)

20 September 2017

title

Oral valgancyclovir versus intravenous gancyclovir for cytomegalovirus prophylaxis in kidney transplant recipients. (English)

1 reference

20 September 2017

0 references

T Said

1

1 reference

20 September 2017

M R N Nampoory

2

1 reference

20 September 2017

A S Pacsa

3

1 reference

20 September 2017

S Essa

4

1 reference

20 September 2017

N Madi

5

1 reference

20 September 2017

N Fahim

6

1 reference

20 September 2017

M Abraham

7

1 reference

20 September 2017

P Nair

8

1 reference

20 September 2017

T Al-Otaibi

9

1 reference

20 September 2017

M A Halim

10

1 reference

20 September 2017

K V Johny

11

1 reference

20 September 2017

M Al-Mousawi

12

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

Transplantation Proceedings

20 September 2017

published in

1 reference

20 September 2017

volume

39

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

997-999

1 reference

Infectious disease complications of renal transplantation

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.046

Viral Infection in the Renal Transplant Recipient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.046

New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.046

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.046

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.046

Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.046

Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.046

10.1016/J.TRANSPROCEED.2007.03.046

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference